Treatment of attention-deficit/hyperactivity disorder

Details Treatment of attention-deficit/hyperactivity disorder Treatment of attention-deficit/hyperactivity disorder

A - Human Necessities

61

K

A61K 31/535 (2006.01) A61K 31/5375 (2006.01)

Patent

CA 2304112

Reboxetine is used to treat attention-deficit/hyperactivity disorder.

La réboxetine est utilisée pour traiter les troubles liés à l'hyperactivité et au déficit de l'attention.

Affiliated with

Also associated with

Rating

Treatment of attention-deficit/hyperactivity disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of attention-deficit/hyperactivity disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of attention-deficit/hyperactivity disorder will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1454908